• standardize definitions of key elements of the schedule, and relevant health outcomes;
  • establish research priorities on the basis of epidemiological evidence, biological plausibility, and feasibility; and
  • continue to fund and support the Vaccine Safety Datalink project to study the safety of the recommended immunization schedule.


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement